Therapeutics for the treatment of neuro-metabolic diseases
MedDay has raised €34M across 1 funding round from 3 investors, most recently a Series B round in Apr 2016. Based in Paris, France; founded 2011; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-04-01 | Series B | €34M |
| Bpifrance,Edmond de Rothschild Venture Capital,Sofinnova Partners |
| View deal → |
